“Ferredoxin 1 identified as immune regulator and therapeutic target for glioblastoma in study of cuproptosis-related genes”

https://pubmed.ncbi.nlm.nih.gov/38114959

A study based on cuproptosis-related genes has identified Ferredoxin 1 as an immune regulator and potential therapeutic target for glioblastoma, associated with poor prognosis, metabolic processes, chemotherapy drug response, and immune cell infiltration.